Yonhap Infomax NewsJan 7
Brokerages, including JP Morgan, have raised their target prices for Samsung Biologics, citing improved earnings forecasts, U.S. plant acquisition, and favorable market conditions.
#YonhapInfomax #SamsungBiologics #JPMorgan #TargetPrice #CDMO #PlantAcquisition #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=98679
Brokerages Raise Target Price for Samsung Biologics—JP Morgan Sets High at 2.6 Million Won

Brokerages, including JP Morgan, have raised their target prices for Samsung Biologics, citing improved earnings forecasts, U.S. plant acquisition, and favorable market conditions.

Yonhap Infomax